In vivo biocompatibility study of ABA triblock copolymers consisting of poly(L-lactic-eo-glycolic acid) A blocks attached to central poly(oxyethylene) B blocks

Journal of Biomedical Materials Research

Volumn 30, Issue 1, 1996, Pages 31-40

  Ronneberger, Birgit ^a   Kao, Weiyuan John ^b   Andersen, James M ^b   Kissel, Thomas ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCK COPOLYMERS; IMPLANTS (SURGICAL); PHYSIOLOGICAL MODELS;

CAGE IMPLANT; INFLAMMATORY TISSUE REACTION; RATS; TEST SYSTEM;

BIOCOMPATIBILITY;

ALKALINE PHOSPHATASE; COPOLYMER; POLYGLACTIN; POLYOXYETHYLENE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; CONTROLLED STUDY; ENZYME ACTIVITY; GIANT CELL; IMPLANTATION; INFLAMMATION; MACROPHAGE; MOLECULAR WEIGHT; NONHUMAN; RAT;

ALKALINE PHOSPHATASE; ANIMALS; BIOCOMPATIBLE MATERIALS; CELL ADHESION; EXUDATES AND TRANSUDATES; FEMALE; GIANT CELLS, FOREIGN-BODY; LACTIC ACID; LEUKOCYTE COUNT; MATERIALS TESTING; MOLECULAR WEIGHT; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; POLYMERS; PROSTHESES AND IMPLANTS; RATS; RATS, SPRAGUE-DAWLEY; SURFACE PROPERTIES;

EID: 0030064723     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-4636(199601)30:1<31::aid-jbm5>3.0.co;2-s     Document Type: Article

References (36)

1. D. Lewis, "Controlled release of bioactive agents from lactide/glycolide polymers," In Biodegradable polymers as drug delivery systems, M. Chasin and R. Langer (eds.), Marcel Dekker, New York, 1990, pp. 1-41.
2. D. F. Williams, ed., Fundamental aspects of biocompatibility, Vol. I, CRC Press, Boca Raton, FL, 1981.
3. J. Schakenraad and P. Dijkstra, "Biocompatibility of poly (DL-lactic acid/glycine) copolymers," Clin. Mater. 7, 253-269 (1991).
4. Y. Ogawa, H. Okada, M. Yamamoto, and T. Shimamoto, "In vitro release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lactic/glycolic) acids and in vivo degradation of these polymers," Chem. Pharmacol. Bull., 36, 2576-2581 (1988).
5. C. Pitt, M. Gratz, G. Kimmel, J. Surles, and A. Schindler, "Aliphatic polyesters II. The degradation of poly(D,L lactide), poly(caprolactone) and their copoymers in vivo," Biomaterials, 2, 215-220 (1981).
6. M. Vert, S. Li, G. Spenlehauer, and P. Guerin, "Bioresorbability and biocompatibility of aliphatic polyesters," in Degradation and biocompatibility of synthetic degradable polymers, D. F. Williams (ed.), CRC Press, Boca Raton, FL, 1990.
7. D. Wise, T. Fellman, J. Sanderson, and R. Wentworth, "Lactic/glycolic acid polymers," in Drug carriers in biology and medicine, G. Gregoiadis (ed.), Academic Press, New York, 1979, pp. 237-270.
8. D. Williams, "Enzyme hydrolysis of polylactic acid," Eng. Med. 10, 5-7 (1981).
9. D. Bodmer, T. Kissel, and E. Trächslin, "Factors influencing the release of peptides and proteins from biodegradable parenteral depot systems," J. Controlled Release, 21, 129-138 (1992).
10. D. Gilbert and S. Kim, "Macromolecular release from collagen monolithic devices," J. Biomed. Mater. Res., 24, 1221-1239 (1990).
11. Y. Li and T. Kissel, "Synthesis and properties of biodegradable ABA triblock copolymers consisting of poly(L-lactic acid) or poly(L-lactic-co-glycolic acid) A-blocks attached to central poly(oxyethylene) B-blocks," J. Controlled Release, 27, 247-257 (1993).
12. V. Bowe, in Industrial hygiene and toxicology, Vol. II, F. A. Patty (ed.), Wiley, New York, 1510-1515 (1963).
13. M. Winer and I. Bernstein, in Adverse reactions to drug formulation agents, Marcel Dekker, New York, 1989, pp. 101-111.
14. R. Marchant, A. Hiltner, C. Hamlin, A. Rabinovitch, R. Stobodkin, and J. M. Anderson, "In vivo biocompatibility studies. I. The cage implant system and a biodegradable polymer," J. Biomed. Mater. Res., 17, 301-325 (1983).
15. D. Gilding, "Biodegradable polymers," in Biocompatibility of implant materials. Vol. 2, D. F. Williams (ed.), CRC Press, Boca Raton, FL, 1981, pp. 210-232.
16. Z. Grubisic, P. Rempp, and H. Benoit, "A universal calibration for gel permeation chromatography," J. Polym. Sci. B, 5, 753-759 (1967).
17. S. Bernatchez, A. Merkli, C. Tabatabay, R. Gurney, Q. Zhao, J. Anderson, and J. Heller, "Biotolerance of a semisolid hydrophobic biodegradable poly(orthoester) for controlled drug delivery," J. Biomed. Mater. Res., 27, 667-681 (1993).
18. K. Spilizewski, R. Marchant, C. Hamlin, J. Anderson, T. Tice, T. Dappert, and W. Meyers, "The effect of hydrocortisone acetate loaded poly(D, L-lactide) films on the inflammatory response," J. Controlled Release, 2, 197-203 (1985).
19. J. Anderson, "In vivo biocompatibility of implantable delivery systems and biomaterials," Eur. J. Pharmacol. Biopharmacol., 40, 1-8 (1994).
20. P. Wilkinson, Chemotaxis and inflammation, Churchill-Livingston, London, 1974.
21. J. Schakenraad, M. Hardonk, J. Feijen, J. Molenaar, and P. Nieuwenhuis, "Enzymatic activity toward poly(L-lactic acid) implants," J. Biomed. Mater. Res., 24, 529-545 (1990).
22. Q. H. Zhao, N. Topham, J. M. Anderson, A. Hiltner, G. Lodoen, and C. R. Payet, "Foreign body giant cells and polyurethane biostability: In vivo correlation of cell adhesion and surface cracking," J. Biomed. Mater. Res., 25, 177-183 (1991).
23. J. M. Anderson and K. M. Miller, "Biomaterials biocompatibility and the macrophage," Biomaterials, 5, 5-10 (1984).
24. J. M. Anderson, "Inflammatory response to implants," ASAIO Trans., 11, 101-107 (1988).
25. N. Ziats, K. Miller, and J. Anderson, "In vitro and in vivo interactions of cells with biomaterials," Biomaterial, 9, 5-13 (1988).
26. R. B. Johnston, "Monocytes and macrophages," N. Engl. J. Med., 319, 747 (1988).
27. J. Papadimitriou, T. Robertson, and M. Walters, "An analysis of the phagocytic potential of multinucleate foreign body giant cells," Am. J. Pathol., 78, 343-355 (1975).
28. T. Salthouse, "Some aspects of macrophage behaviour at the implant interface" J. Biomed. Mater. Res., 18, 395-401 (1984).
29. C. Behling and M. Spector, "Quantitative characterization of cells at the interface of long-term implants of selected polymers," J. Biomed. Mater. Res., 20, 653-666 (1986).
30. D. O'Hagan, H. Jeffery, and S. Davis, "The preparation and characterization of poly(lactide-co-glycolide) microparticles: III. Microparticle/polymer degradation rates and the in vitro release of a model protein," Int. J. Pharmacol., 103, 37-45 (1994).
31. G. Lord, "Regulation and reason for biocompatibility testing," in Techniques of biocompatibility testing, D. F. Williams (ed.), Vol. 1, CRC Press, Boca Raton, FL, 1986, pp. 1-33.
32. G. Visscher, R. Robison, H. Maulding, J. Fong, J. Pearson, and G. Argentieri, "Biodegradation of and tissue reaction to 50:50 poly(DL-lactide-co-glycolide) microcapsules," J. Biomed. Mater. Res., 19, 349-365 (1985).
33. G. Visscher, R. Robison, and G. Argentieri, "Tissue response to biodegradable injectable microcapsules," J. Biomed. Appl., 2, 118-131 (1987).
34. N. Maroudas, "Adhesion and spreading of cells on charged surfaces," J. Theor. Biol. 49, 417-424 (1975).
35. R. Baier, A. Meyer, J. Natiella, R. Natiella, and J. Carter, "Surface properties determine bioadhesive outcomes - Methods and results," J. Biomed. Mater. Res., 18, 337-355 (1984).
36. A. Hogt, D. Gregonis, J. Andrade, S. Kim, J. Dankert, and J. Feijen, "Wettability and zeta-potentials of a series of methacrylate polymers and copolymers," J. Colloid Interface Sci., 106, 289-298 (1985).